Key Takeaways
- Record profit, confident tone: Profit after tax tripled YoY to a record ₹22 crores as the worst of COVID-era asset quality stress receded, and management declared “the worst is behind us.”
- Disbursement engine running hot: Disbursements grew 61.2% YoY to ₹478 crores, driven by strong rural demand and a fully paperless loan origination system that cut turnaround time by two days.
- Asset quality is healing, with one small bruise: GNPA improved 100 bps from March 2022, though MFI GNPA ticked up 30 bps sequentially on slight Maharashtra pressure and a 20 bps hit from new RBI NPA recognition rules.
- MSME is the quiet profit engine: The MSME book is generating negative impairment cost (recoveries exceeding provisions), with rejection rates above 70% signalling cherry-picking, not sub-priming.
- What to watch next quarter: Whether the MFI GNPA blip in Maharashtra stabilises, the pace of geographic diversification into Bihar and Haryana, and any movement on co-lending or the long-delayed Micro LAP product.
Growth & Disbursement Trajectory
- Disbursement surge: Q3 disbursements hit ₹478 crores, up 61.2% YoY, supported by high demand in microfinance and improving on-ground recovery in rural and semi-rural markets.
- AUM scaling: AUM grew 57.2% YoY to ₹1,642 crores, aided by the new LOS and LMS systems that made the entire microfinance process paperless, including digital signatures.
- Ticket size reset: Average MFI ticket size rose from ₹36,000 to ₹46,000 as customers shifted to higher cycles, COVID-era conservative sizing unwound, and the company aligned with an industry-wide trend, since customers are more sensitive to ticket size and turnaround time than interest rates.
- Customer base quality: 10–15% of customers left MFI due to COVID defaults, so the remaining pool is those who repaid through the crisis; post-COVID default data shows little correlation between ticket size and default probability, making the slightly higher risk on larger tickets acceptable.
- Income lag vs disbursements: QoQ interest income rose only 4% despite ~70% disbursement growth because disbursements generate income over two years, and ~₹100 crores of portfolio sales meant that income was captured in gain on sale, not the interest income line.
- Long-term growth target: Management targets a 35–40% CAGR and expects FY24 to be in a similar neighbourhood.
Aalok Patel: "We believe the worst is behind us and we are well poised to achieve growth and harvest the benefits of fairer weather."
Asset Quality & Provisioning
- Headline improvement: GNPA improved 100 bps and Net NPA improved 50 bps from March 2022, driven by better collection efforts and post-COVID asset quality recovery.
- MFI blip contained: MFI GNPA moved from 3% to 3.3% sequentially, a ~0.15% overall impact, due to slight pressure in Maharashtra; management described it as a small variation, well under control.
- RBI guideline impact: New RBI rules requiring an asset to stay NPA once classified at 90+ DPD added ~20 bps to NPAs; total impact across the company was not more than ~0.2%.
- Provisioning buffer build: Total cumulative provisions stand at 4.6% vs gross NPA of 3.37%; pre-COVID MFI GSK was just 0.53% in March 2020, and management expects provisions may go up further as a buffer for a rainy day.
- Forward credit cost: Annualized credit cost of 2–2.5% is expected on the post-COVID microfinance book of ~₹1,500 crores going forward.
- MSME outperformance: The MSME book is generating negative impairment cost, with recoveries exceeding provisions.
Aalok Patel: "Pre COVID was micro-finance, in particular, was a very different regime because the entire sector probably was reporting, less than 1.5% of NPAs. We were, in March 2020, GSK in MFI was 0.53%. And the hope is that we stock away for a rainy day, so I don't expect this number to go down. In fact, it might go up, the provisions."
MSME: The Quiet Profit Engine
- Competitive positioning: Arman competes with money lenders charging 5–10% per month (60–120% annualized), not 40%; its effective flat rate is ~15–16%, and customers are not very price-sensitive.
- Cherry-picking, not sub-priming: Rejection rates are north of 70%, which management offers as provable evidence of disciplined underwriting.
- Pricing flexibility: There is no requirement to cut rates today, but if competition increases, management is happy to cut and there is probably room to do so given current margins.
- Growth caution: Very quick growth in MSME is difficult and slightly dangerous; the segment demands careful, customer-by-customer understanding, so short-term growth rates like JLG microfinance are hard to match.
- Long-run ambition: Management is very bullish on MSME and believes it may overtake microfinance in the long run.
Aalok Patel: "Certainly, our rejection rates are north of 70% even today. And that is a provable facts, so I would say that we are cherry picking, not sub-priming it."
Geographic Diversification
- Concentration reduction: Gujarat concentration has fallen from 80% in March 2017 to 29% now; the top 3 states now account for ~60% of AUM, and this is expected to keep declining.
- New state entry: The company recently entered Bihar and Haryana. Bihar is doing excellently, better than anticipated; Haryana is doing fine but growth is a little slow.
- Expansion strategy: Focus will continue on extending presence into newer districts in existing states while exploring opportunities in new states.
Margins, Funding & Liability Management
- Finance cost pressure: Finance costs increased significantly QoQ from interest on CCDs, provision on OCRPS (~₹5 crores), and ~70–80 bps weighted average interest rate pressure from RBI repo rate hikes.
- Liquidity carry cost: Higher liquidity maintained to support increasing disbursements added to financial costs; Q4 is expected to carry slightly more cash to service slower debt volumes in Q1, which is the usual seasonal trend.
- Cost of borrowing outlook: Management tries to maintain borrowing costs at current levels but expects another 25 bps increase, dependent on environmental factors; the MFI-1 grading could cause some softening from existing lenders.
- NIM trajectory: Yields are likely to increase marginally as the older, lower-interest portfolio runs off and is replaced by slightly higher-margin portfolios.
- Liability diversification: No tightness in sourcing liabilities currently; the company is diversified across products and lender buckets, so if one lender type is inactive, others are willing.
- CCD/OCRPS conversion: CCDs (₹76 crores) are compulsorily convertible by March 2024; OCRPS (₹38 crores) conversion depends on price at the time, and management is not too worried. The additional equity instrument burden of ~₹4.5–5 crores per quarter is expected to be far offset by extra income from portfolio growth leveraged on the ₹115 crores equity.
- MLD tax status: Existing MLDs (~₹45 crores) are unaffected by the budget tax change since the company only pays interest regardless of tax regime; future investor interest in MLDs is uncertain and may shift to NCDs with regular taxation.
Digital & Operational Upgrades
- Paperless originations: The new LOS and LMS implementation has made the entire microfinance process completely paperless, including loan documentation using digital signatures; the company claims to be one of the first MFIs in India with 100% paperless loan originations.
- Digital underwriting stack: Facial recognition with ML for KYC, OCR verification, penny drops for bank account verification, voter ID verification, geo-tagging at every step, center risk categorization, e-signatures, and auto-algorithms for credit bureau data mean 80% of customers’ credit bureau data is auto-approved without human review; overall turnaround time reduced by ~2 days.
- New product launch: Individual Business Loans (IBL) have been introduced for graduating microfinance customers without group guarantees, on an individual basis, with cashless repayment methodology and higher underwriting.
- MFI-1 grading: In January 2023, the microfinance business was assigned the highest-ever grading of MFI-1 by CARE Ratings, which should improve credit ratings with most lenders.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| AUM growth | 35–40% CAGR target; FY24 expected in similar neighbourhood | FY24 |
| Leverage ceiling | Typically try not to go beyond 5x debt-to-equity ratio | Ongoing |
| Credit cost | Annualized 2–2.5% loan loss cost on post-COVID MFI book (~₹1,500 crores) | Going forward |
| Provisioning direction | Provisions may go up, not down, as a buffer for a rainy day | Ongoing |
| Cost of borrowing | Try to maintain at current levels; might see another 25 bps increase | Near term |
| Geographic concentration | Top-3-state concentration to continue declining | Ongoing |
| CCD conversion | ₹76 crores compulsorily convertible | By March 2024 |
| Co-lending / BC arrangements | Open to exploring on a purely commercial basis if opportunity arises | No timeline |
| Micro LAP product | On to-do list since pre-COVID; something to consider now that things have stabilized | No timeline |
| PRAYAS scheme | Evaluating for low-scale MSME workers; hopeful to use it | Next few quarters |
Key Metrics
| Metric | Q3 FY23 |
|---|---|
| Assets under management (AUM) | ₹1,642 cr, +57.2% YoY and +14.4% QoQ |
| AUM mix | 81% micro-finance, 13% MSME, 4% 2-wheeler, 2% individual business loans |
| Disbursements | ₹478 cr, +61.2% YoY and +72% QoQ |
| MFI disbursements | ₹406 cr, +68.8% YoY and +83.5% QoQ |
| Gross total income | ₹103 cr, +75.6% YoY and +11.2% QoQ |
| Net interest margin (NIM) | 14.8% |
| Pre-provision operating profit | ₹38 cr, +206% YoY and +10.3% QoQ |
| Profit after tax | ₹22 cr, highest ever, tripled YoY |
| Consolidated GNPA | 3.37%, improved 100 bps from March 2022 |
| Net NPA | 0.15%, improved 50 bps from March 2022 |
| Cumulative provisions | ₹70 cr, covering 4.6% of on-book portfolio |
| Collection efficiency (January 2023) | 98.3% overall; MFI 98.4%, MSME 98.1%, 2-wheeler 96.5% |
| Total borrowings | ₹1,518 cr, excluding ₹53 cr debt component of OCRPS and CCDs |
| Debt-to-equity ratio | 3.6x (IND-AS, including equity split of CCDs and OCRPS) |
| Capital adequacy – Arman standalone | 48% |
| Capital adequacy – subsidiary Namra | 21.6% |
| Branch network | 321 branches across 8 states; 2,857 team members |
| Cost of borrowing (9M FY23) | 12.7% to 13.0% consolidated |
| Long-term CAGR growth target | 35% to 40% |
| Comfortable debt-to-equity leverage ceiling | not above 5x |
| MFI average ticket size | ₹46,000, up from ₹36,000 as of Sep '22 |
| IBL portfolio share of AUM | 2.3% as of 31st December 2022, with 100% repayment rate and 100% cashless collections |
| Direct assignment transaction size | ~₹100 cr, gain of ~₹6.6 cr vs ~₹5.8 cr a year ago (per an analyst's math) |
| Interest expense from OCRPS and CCDs | ~₹4.5–5 cr per quarter until conversion by March '24 |
| New RBI NPA guidelines impact | ~0.2% increase on overall NPAs |
| MSME rejection rate | north of 70% |
| Pre-COVID MFI GNPA (March 2020) | 0.53% |
| Expected annualized credit cost on post-COVID book | 2%–2.5% on ~₹1,500 cr book |